Prevention and treatment of invasive aspergillosis in Slovenia: data obtained in »OSPIA« observational clinical study
Abstract
Background: Invasive aspergillosis (IA) is a common opportunistic infection in patients with critical neutropenia. Mostly, patients are located on hematological wards. In Slovenija, because of unsuitable hospital enviroment the problem of IA is huge. With clinical observational study OSPIA (»Observational Study of Patients with Invasive Aspergillosis«) we tried to evaluate prevention, diagnostics and treatment of IA. Methods: During three-year period we included 55 patients with IA. Besides the primary disease, we evaluated risk factors, prevention measures, diagnostic approaches and treatment of IA. Results: In most cases, patients had acute leukemia and major risk factor was critical neutropenia. Because of inadequate hospital conditions, almost every patient received prophylaxis with posoconasol. The most frequently used diagnostic procedure is test for galactomannan antigenemia, followed by radiological approach. Most casas were treated with amphothericin, followed with caspofungin. The treatment was not effective in cases of therapy-refractory primary hematological disease. Conclusions: In Slovenia, IA remains a huge problem in patients with critical neutropenia. The primary reason lays in inadequate hospital treatment conditions for hematological patients. The latter we try to mitigate with posoconasole prophylaxis.Downloads
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.